98 related articles for article (PubMed ID: 32980342)
1. Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank.
Fan X; Liu Z; Miyata T; Dasarathy S; Rotroff DM; Wu X; Poulsen KL; Nagy LE
Gastroenterology; 2021 Jan; 160(1):455-458.e5. PubMed ID: 32980342
[No Abstract] [Full Text] [Related]
2. COVID-19 and death at home.
Ashton J
J R Soc Med; 2021 May; 114(5):275-276. PubMed ID: 34028290
[No Abstract] [Full Text] [Related]
3. Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection.
Hariyanto TI; Prasetya IB; Kurniawan A
Dig Liver Dis; 2020 Dec; 52(12):1410-1412. PubMed ID: 33092998
[No Abstract] [Full Text] [Related]
4. Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study.
Kappelmann N; Arloth J; Georgakis MK; Czamara D; Rost N; Ligthart S; Khandaker GM; Binder EB
JAMA Psychiatry; 2021 Feb; 78(2):161-170. PubMed ID: 33079133
[TBL] [Abstract][Full Text] [Related]
5. Prospective associations between vitamin D and depression in middle-aged adults: findings from the UK Biobank cohort.
Ronaldson A; Arias de la Torre J; Gaughran F; Bakolis I; Hatch SL; Hotopf M; Dregan A
Psychol Med; 2022 Jul; 52(10):1866-1874. PubMed ID: 33081855
[TBL] [Abstract][Full Text] [Related]
6. Alcohol Consumption is Associated with Poor Prognosis in Obese Patients with COVID-19: a Mendelian Randomization Study using UK Biobank.
Fan X; Liu Z; Poulsen KL; Wu X; Miyata T; Dasarathy S; Rotroff DM; Nagy LE
medRxiv; 2020 Nov; ():. PubMed ID: 33269370
[TBL] [Abstract][Full Text] [Related]
7. Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis.
Li GF; An XX; Yu Y; Jiao LR; Canarutto D; Yu G; Wang G; Wu DN; Xiao Y
Gut; 2021 Sep; 70(9):1806-1808. PubMed ID: 33172925
[No Abstract] [Full Text] [Related]
8. Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19.
Ramachandran P; Perisetti A; Gajendran M; Jean-Louis F; Bansal P; Dwivedi AK; Goyal H
Eur J Gastroenterol Hepatol; 2022 Feb; 34(2):137-141. PubMed ID: 33252418
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitors and Mortality in Individuals With COVID-19.
Aby ES; Rodin H; Debes JD
Am J Gastroenterol; 2020 Nov; 115(11):1918. PubMed ID: 33156113
[No Abstract] [Full Text] [Related]
10. Might proton pump or sodium-hydrogen exchanger inhibitors be of value to ameliorate SARs-CoV-2 pathophysiology?
Conrad KP
Physiol Rep; 2021 Jan; 8(24):e14649. PubMed ID: 33369281
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19.
Zhang XY; Li T; Wu H; Ling Y; Qian ZP; Chen L
J Inflamm Res; 2021; 14():287-298. PubMed ID: 33574690
[TBL] [Abstract][Full Text] [Related]
12. Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19.
Elmunzer BJ; Wolf BJ; Scheiman JM; Tierney WM; Taylor JR;
Gastroenterology; 2021 Mar; 160(4):1417-1422.e14. PubMed ID: 33189702
[No Abstract] [Full Text] [Related]
13. Remdesivir for Adults With COVID-19 : A Living Systematic Review for American College of Physicians Practice Points.
Wilt TJ; Kaka AS; MacDonald R; Greer N; Obley A; Duan-Porter W
Ann Intern Med; 2021 Feb; 174(2):209-220. PubMed ID: 33017170
[TBL] [Abstract][Full Text] [Related]
14. Risk of COVID-19 in Patients Taking Proton Pump Inhibitors.
Hadi YB; Naqvi SF; Kupec JT
Am J Gastroenterol; 2020 Nov; 115(11):1919-1920. PubMed ID: 33156115
[No Abstract] [Full Text] [Related]
15. Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis.
Kow CS; Hasan SS
J Intern Med; 2021 Jan; 289(1):125-128. PubMed ID: 33078881
[No Abstract] [Full Text] [Related]
16. Sleep disorders are associated with acetaminophen-induced adverse reactions and liver injury.
Fan X; Zhang K; Wang X; Zhang X; Zeng L; Li N; Han Q; Liu Z
Biomed Pharmacother; 2021 Feb; 134():111150. PubMed ID: 33395599
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort.
Lee SW; Yang JM; Yoo IK; Moon SY; Ha EK; Yeniova AÖ; Cho JY; Kim MS; Shin JI; Yon DK
Gut; 2021 Oct; 70(10):2013-2015. PubMed ID: 33303566
[No Abstract] [Full Text] [Related]
18. Histamine receptors and COVID-19.
Ennis M; Tiligada K
Inflamm Res; 2021 Jan; 70(1):67-75. PubMed ID: 33206207
[TBL] [Abstract][Full Text] [Related]
19. Concomitant right coronary aneurysm and total occlusion of left anterior descending artery and left circumflex artery.
Li G; Li Q; Li Y; Yan Y
Eur Heart J; 2020 Nov; 41(42):4144. PubMed ID: 33128064
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
